Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded on September 8, 2022, SIIF Impact Capital, Inc. is based in Shibuya, Tokyo, Japan. The firm specializes in impact investing, targeting next-generation industries that create both economic and social value. SIIFIC is focused on addressing social issues related to wellness, particularly in the context of Japan's aging population.
SIIF Impact Capital invests in startups that enhance wellness literacy and social capital, particularly within the health and wellness sectors. Their investment strategy employs system thinking and globally recognized impact investment methodologies. The firm aims to tackle social challenges associated with wellness in Japan.
Notable portfolio companies include ジェイファーマ株式会社 (Jay Pharma, Inc.), which develops innovative drugs for unmet medical needs; ORTHOREBIRTH株式会社 (Orthorebirth, Inc.), a medical device startup producing absorbable artificial bone scaffolds; and Proximar株式会社 (Proximar, Inc.), focused on environmentally friendly land-based aquaculture of Atlantic salmon. Other investments include 株式会社C-HASプラス (C-HAS Plus, Inc.), developing health span analysis technology, and 株式会社Personal Health Tech (Personal Health Tech, Inc.), which offers technology-driven health management solutions.
Submit through their form at https://siific.co.jp/contact/.
SIIF Impact Capital typically participates in early-stage funding rounds, often leading investments in their focus sectors.
The firm is open to follow-on investments, particularly in companies that align with their impact investment strategy and demonstrate growth potential.
Details about the specific size of SIIF Impact Capital's current fund are not publicly available.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.